ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Viagra, Levitra and Cialis Appear to Up Survival in Diabetic Men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 20259" data-attributes="member: 3"><p>In a preliminary study of men with type 2 diabetes, the use of phosphodiesterase type-5 (PDE5) inhibitors was associated with reduced all-cause mortality, even in men who had a previous myocardial infarction (MI), during a 5-year follow-up.</p><p></p><p>A second study, with a few of the same coauthors, came up with similar results in a different population of men with type 2 diabetes, some of whom were also receiving testosterone therapy. This showed that PDE5 inhibitors and testosterone — in a population appropriately receiving the male hormone due to diagnosed hypogonadism — both independently reduce mortality.</p><p></p><p>The two studies were presented during a late-breaking poster session at the recent <a href="http://www.medscape.com/viewcollection/33412" target="_blank">American Diabetes Association (ADA) 2015 Scientific Sessions</a>.</p><p></p><p>The findings appear contrary to what might be expected, coauthor of both studies, Dr Adrian H Heald (University of Manchester, United Kingdom), told <em>Medscape Medical News</em>.</p><p></p><p>Because "erectile dysfunction is a marker of endothelial dysfunction — small-vessel dysfunction — and therefore, if anything, [men with erectile dysfunction] would be more likely to have a [potentially fatal] myocardial infarction, and the fact that we pushed [the risk of mortality] the other way is, I think, a pretty significant finding," he said.</p><p></p><p>However, this line of research has important caveats, Dr Simon G Anderson (University of Manchester), lead author of the first study (which did not involve testosterone), cautioned. For example, the researchers lacked information about other relevant factors that could contribute to longevity, such as frequency of sexual activity or lack of depression.</p><p></p><p><a href="http://www.medscape.com/viewarticle/846925" target="_blank">PDE5 Inhibitors Appear to Up Survival in Diabetic Men</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 20259, member: 3"] In a preliminary study of men with type 2 diabetes, the use of phosphodiesterase type-5 (PDE5) inhibitors was associated with reduced all-cause mortality, even in men who had a previous myocardial infarction (MI), during a 5-year follow-up. A second study, with a few of the same coauthors, came up with similar results in a different population of men with type 2 diabetes, some of whom were also receiving testosterone therapy. This showed that PDE5 inhibitors and testosterone — in a population appropriately receiving the male hormone due to diagnosed hypogonadism — both independently reduce mortality. The two studies were presented during a late-breaking poster session at the recent [URL='http://www.medscape.com/viewcollection/33412']American Diabetes Association (ADA) 2015 Scientific Sessions[/URL]. The findings appear contrary to what might be expected, coauthor of both studies, Dr Adrian H Heald (University of Manchester, United Kingdom), told [I]Medscape Medical News[/I]. Because "erectile dysfunction is a marker of endothelial dysfunction — small-vessel dysfunction — and therefore, if anything, [men with erectile dysfunction] would be more likely to have a [potentially fatal] myocardial infarction, and the fact that we pushed [the risk of mortality] the other way is, I think, a pretty significant finding," he said. However, this line of research has important caveats, Dr Simon G Anderson (University of Manchester), lead author of the first study (which did not involve testosterone), cautioned. For example, the researchers lacked information about other relevant factors that could contribute to longevity, such as frequency of sexual activity or lack of depression. [URL="http://www.medscape.com/viewarticle/846925"]PDE5 Inhibitors Appear to Up Survival in Diabetic Men[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Viagra, Levitra and Cialis Appear to Up Survival in Diabetic Men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top